Healthcare Industry News: Sanofi-aventis
News Release - October 1, 2007
Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human ResourcesPITTSBURGH, Pa., Oct. 1 (HSMN NewsFeed) -- Mylan Laboratories Inc. (NYSE: MYL ) today announced the appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources (HR), effective October 22, 2007. Mr. Lillback brings to Mylan more than 25 years of HR experience. He joins from Sanofi-aventis where he served as Vice President of Human Resources, U.S., with responsibility for HR leadership for more than 16,000 employees. Prior to joining Sanofi-aventis, Mr. Lillback held executive HR positions with LaRoche Industries and Kaiser Chemicals.
Mr. Lillback has extensive experience in establishing global HR operations, processes and policies; creating and implementing effective HR business strategies for successful and sustainable growth; and implementing improved benefit programs aligned with pharmaceutical industry trends. He also has demonstrated expertise in the recruitment and training of large sales teams and implementing HR information systems to ensure efficient management of talent, performance and compensation.
Mylan Vice Chairman and CEO Robert J. Coury commented: "As I've stated many times, we are clearly focused on building the management team at Mylan with the best and the brightest talent, and I am therefore pleased to welcome David to the Mylan family. With Mylan's significant global expansion, it becomes even more critical that we have in place the tools to identify, grow and develop talent around the world. David will ensure that our human resources activities are closely aligned with the fast-evolving needs of our business and that Mylan is the first choice for high potential candidates in the pharmaceutical sector. David will also ensure that we continue to provide the highest level of HR services and support for our existing employees around the world. Mylan's employees have always been our greatest asset and ensuring that they have the resources they need remains one of our greatest priorities."
Mr. Lillback earned an MBA and a bachelor's of science degree from Lake Erie College in Painesville, Ohio. He also has completed the International Executive Program at INSEAD business school in France.
Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc., and a controlling interest in Matrix Laboratories Limited, India. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products. For more information about Mylan, please visit www.mylan.com.
Source: Mylan Laboratories
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.